Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty
Author:
Affiliation:
1. University of Pennsylvania Philadelphia
2. University of Pennsylvania and Philadelphia Veterans Affairs Medical Center Philadelphia
3. University of Alabama at Birmingham
Funder
National Institutes of Health
Rheumatology Research Foundation
Research and Development
Publisher
Wiley
Subject
Rheumatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.23209
Reference45 articles.
1. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
2. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
3. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
4. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
5. Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studies
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis;Journal of the American Academy of Dermatology;2024-08
2. Dermatology practice updates in mycobacterial disease;International Journal of Dermatology;2023-12-14
3. Perioperative immunosuppressive therapy and coronary ostial angioplasty for unstable angina with Takayasu arteritis;Journal of Cardiology Cases;2023-12
4. Infection prevention and vaccination in the rheumatic diseases;Joint Bone Spine;2023-09
5. Updated American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty 2022;Rheumatology Science and Practice;2023-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3